Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

ClinicalTrials.gov ID: NCT07217587

Public ClinicalTrials.gov record NCT07217587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 13, 2026, 2:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Nipocalimab vs Efgartigimod for Patients With Generalized Myasthenia Gravis in a Randomized, Open-label, Phase 3b, Interventional Trial Including Within Class Switching From Efgartigimod to Nipocalimab

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess how well nipocalimab works when compared to efgartigimod in participants with generalized myasthenia gravis (a condition in which body's immune system mistakenly attacks and damages the connection between nerves and muscles causing muscle weakness).

Study identification

NCT ID
NCT07217587
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
115 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2026
Primary completion
Sep 27, 2027
Completion
Jan 28, 2029
Last update posted
Aug 27, 2026

2026 – 2029

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Neurology Center of North Orange County Fullerton California 92835 Recruiting
The Neurology Group Pomona California 91767 Recruiting
Advanced Neurology of Colorado Fort Collins Colorado 80528 Completed
University of Connecticut Farmington Connecticut 06030 Recruiting
SFM Clinical Research LLC Boca Raton Florida 33487 Recruiting
HSHS St. Elizabeth's Hospital O'Fallon Illinois 62269 Recruiting
Josephson Wallack Munshower Neurology, PC Indianapolis Indiana 46256 Recruiting
Tulane Center for Clinical Research New Orleans Louisiana 70112 Recruiting
Henry Ford Hospital Detroit Michigan 48202 Recruiting
Equity Medical New York New York 10023 Recruiting
Velocity Clinical Research, Inc. Raleigh North Carolina 27607 6010 Recruiting
Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27157 Recruiting
Neurology Clinic, PC Cordova Tennessee 38018 Recruiting
Texas Neurology Dallas Texas 75206 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07217587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2026 · Synced Sep 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07217587 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →